Medical News

RSS

Men with relatively unaggressive prostate tumors unlikely to develop metastatic prostate cancer

Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers at the Brady Urological Institute at Johns Hopkins, who analyzed survival statistics up to 15 years.

1 Sep 2015

North Shore-LIJ researcher compares safety benefits two blood-thinning medications

A large, ambitious contrast of blood-thinning medications used during cardiac stent placement suggests that a very expensive drug offers no clear safety benefits over a much more affordable option, according to a prominent North Shore-LIJ researcher and cardiologist.

1 Sep 2015

New statistical model may help predict patients most likely to benefits from surgical treatment for mesothelioma

A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article in the September 2015 issue of The Annals of Thoracic Surgery.

1 Sep 2015

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar Therapeutics announced today that it has received a $40 million cash payment under a license agreement with AstraZeneca. The payment was triggered by the first commercial sale of MOVENTIG (naloxegol) in Germany.

1 Sep 2015

Finerenone effective in heart failure patients with diabetes and/or chronic kidney disease

In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP].

1 Sep 2015

Survey: Mental health care inaccessible to many Americans

Nearly 90 percent of Americans value mental health and physical health equally, yet about one-third find mental health care inaccessible, and more than four in 10 see cost as a barrier to treatment for most people, according to the results of a new survey released today by the Anxiety and Depression Association of America, the American Foundation for Suicide Prevention and the National Action Alliance for Suicide Prevention.

1 Sep 2015

Defibrillator does not improve outcomes in patients with CRT pacemaker

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the first time today at ESC Congress1 and published in European Heart Journal.

1 Sep 2015

SINTEF researchers develop simulation tool to better understand noise pollution

They're going to build a new road right outside your living room window. The authorities have sent you a 'noise map', but what you really need is to hear what the traffic noise will sound like. Well, soon you can.

1 Sep 2015

SLU scientist receives grant to solve blood-clotting mysteries

Last summer, SLU scientists made a breakthrough discovery about the way in which blood clots. Through X-ray crystallography, they solved the molecular structure of prothrombin, an important blood-clotting protein, revealing an unexpected, flexible role for a "linker" region that may be the key to developing better life-saving drugs.

1 Sep 2015

John Foy & Associates announces new scholarship for college students affected by leukemia

Georgia-based law firm John Foy & Associates announced the offering of a new scholarship for college students who have been affected by leukemia—either as a patient or a loved one.

1 Sep 2015

Treating cancer cells with quizartinib inhibits key metabolic pathway, activates macroautophagy

A study published in The Journal of Cell Biology describes a way to force cancer cells to destroy a key metabolic enzyme they need to survive.

1 Sep 2015

Study: Retrieval of larger thrombi during IAT linked to improved neurological recovery after acute ischaemic stroke

Retrieval of larger thrombi during intra arterial treatment (IAT) is associated with improved neurological recovery after acute ischaemic stroke, according to a sub study of the MR CLEAN trial presented at ESC Congress today by Dr Anouchska Autar, PhD candidate at the Erasmus Medical Centre in Rotterdam, the Netherlands.

1 Sep 2015

IV drug abusers who undergo infective endocarditis surgery face higher risk of reoperation or death

Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.

1 Sep 2015

Preoperative statins linked to reductions in cardiac complications, mortality after noncardiac surgery

Preoperative statins are associated with a 17% reduction in cardiac complications and a 43% reduction in mortality after noncardiac surgery, according to results from the VISION Study presented for the first time today at ESC Congress by Dr Otavio Berwanger, director of the Research Institute HCor, Hospital do Coração (Heart Hospital) in São Paulo, Brazil.

1 Sep 2015

Study calls for new strategies to shape perceptions of patients at risk for falls in hospitals

Falls are the most common adverse event among hospitalized patients, and a study published in the September issue of the American Journal of Critical Care examines an often overlooked element to preventing falls in hospitals: patient perceptions of their personal risk.

1 Sep 2015

Lifestyle changes lead to sharp reduction in strenuousness of daily life

New research from Royal Holloway, University of London has found that changes in lifestyle over the past 30 years have led to a sharp reduction in the strenuousness of daily life, which researchers say may explain why there has been a dramatic rise in obesity.

1 Sep 2015

GARFIELD-AF Registry: All-cause death is most frequent major event in newly diagnosed AF patients

The first-ever two-year outcomes from the Global Anticoagulant Registry in the Field - Atrial Fibrillation (GARFIELD-AF) showcased at ESC Congress 2015 expose that all-cause death was the most frequent major event in more than 17,000 newly diagnosed AF patients, far exceeding the rate of stroke or major bleeding.

1 Sep 2015

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).

1 Sep 2015

Swecure receives US patent approval for preventive allergy treatment

Swecure, a research and development stage biotechnology company primarily focused on developing novel treatments for immunoregulatory diseases such as allergy, IBD and IBS, receives patent approval grant by the US Patent and Trademark Office. The invention relates to a use of bacterial superantigens for the prevention of allergy in children as well as a method for the prevention of inflammatory disorders.

1 Sep 2015

EHR documentation tools should be redesigned to meet physicians’ needs

When physicians prepare for patient visits, one of their first steps is to review clinic notes or health records that recap their patients' medical history. Since the Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009, approximately 78 percent of office-based physicians have adopted electronic health records (EHR).

1 Sep 2015

Medical News

Men with relatively unaggressive prostate tumors unlikely to develop metastatic prostate cancer

North Shore-LIJ researcher compares safety benefits two blood-thinning medications

New statistical model may help predict patients most likely to benefits from surgical treatment for mesothelioma

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Finerenone effective in heart failure patients with diabetes and/or chronic kidney disease

Survey: Mental health care inaccessible to many Americans

Defibrillator does not improve outcomes in patients with CRT pacemaker

SINTEF researchers develop simulation tool to better understand noise pollution

SLU scientist receives grant to solve blood-clotting mysteries

John Foy & Associates announces new scholarship for college students affected by leukemia

Treating cancer cells with quizartinib inhibits key metabolic pathway, activates macroautophagy

Study: Retrieval of larger thrombi during IAT linked to improved neurological recovery after acute ischaemic stroke

IV drug abusers who undergo infective endocarditis surgery face higher risk of reoperation or death

Preoperative statins linked to reductions in cardiac complications, mortality after noncardiac surgery

Study calls for new strategies to shape perceptions of patients at risk for falls in hospitals

Lifestyle changes lead to sharp reduction in strenuousness of daily life

GARFIELD-AF Registry: All-cause death is most frequent major event in newly diagnosed AF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Swecure receives US patent approval for preventive allergy treatment

EHR documentation tools should be redesigned to meet physicians’ needs

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News